Biomarker specific to brain/nerve or specific to neuronal differentiation
    3.
    发明授权
    Biomarker specific to brain/nerve or specific to neuronal differentiation 失效
    特异于脑/神经或特异于神经元分化的生物标志物

    公开(公告)号:US08153764B2

    公开(公告)日:2012-04-10

    申请号:US12531430

    申请日:2008-03-13

    IPC分类号: C07K14/705 C12N15/63

    摘要: The invention provides a polypeptide and a specific partial peptide thereof, as well as a polynucleotide and a specific partial nucleotide thereof, that can be used as a biomarker specific for the brain/nerves or specific for nerve differentiation; an expression vector for such a polynucleotide and a specific partial peptide thereof; a transformant incorporating such an expression vector; an antisense molecule, RNAi-inducing nucleic acid (e.g., siRNA), aptamer, or antibody for such a biomarker, and a composition comprising the same; a mammalian cell or non-human mammal wherein the expression or a function of such a biomarker is regulated; a measuring means (e.g., primer set, nucleic acid probe, antibody, aptamer) for such a biomarker, and a reagent comprising the same and the like.

    摘要翻译: 本发明提供了可用作脑/神经特异性或特异于神经分化的生物标志物的多肽及其特定部分肽以及其多核苷酸和特定的部分核苷酸; 这种多核苷酸及其特定部分肽的表达载体; 包含这种表达载体的转化体; 用于这种生物标志物的反义分子,RNAi诱导核酸(例如siRNA),适体或抗体,以及包含其的组合物; 哺乳动物细胞或非人哺乳动物,其中调节这种生物标志物的表达或功能; 用于这种生物标志物的测量装置(例如,引物组,核酸探针,抗体,适体)和包含该生物标记的试剂等。

    BIOMARKER SPECIFIC FOR CANCER
    5.
    发明申请
    BIOMARKER SPECIFIC FOR CANCER 失效
    生物标志物特异性癌症

    公开(公告)号:US20100100979A1

    公开(公告)日:2010-04-22

    申请号:US12531358

    申请日:2008-03-13

    摘要: It is an object of the present invention to provide diagnostic reagents, pharmaceuticals and the like for particular diseases, and providing means that are useful in developing such reagents, pharmaceuticals and the like. The present invention provides a novel polypeptide and a specific partial peptide thereof, as well as a novel polynucleotide and a specific partial nucleotide thereof, that can be used as cancer-specific biomarkers; an expression vector for such a polynucleotide and a specific partial peptide thereof; a transformant incorporating such an expression vector; an antisense molecule, RNAi-inducing nucleic acid (e.g., siRNA), aptamer, or antibody for a cancer-specific biomarker, and a composition comprising the same; a mammalian cell or non-human mammal wherein the expression or a function of a cancer-specific biomarker is regulated; a measuring means (e.g., primer set, nucleic acid probe, antibody, aptamer) for a cancer-specific biomarker, and a reagent comprising them and the like.

    摘要翻译: 本发明的目的是为特定疾病提供诊断试剂,药物等,并提供可用于开发这些试剂,药物等的方法。 本发明提供了可用作癌症特异性生物标志物的新型多肽及其特异性部分肽,以及其新型多核苷酸及其特定部分核苷酸; 这种多核苷酸及其特定部分肽的表达载体; 包含这种表达载体的转化体; 用于癌特异性生物标志物的反义分子,RNAi诱导核酸(例如siRNA),适体或抗体,以及包含其的组合物; 哺乳动物细胞或非人哺乳动物,其中调节癌特异性生物标志物的表达或功能; 用于癌特异性生物标志物的测量装置(例如,引物组,核酸探针,抗体,适体)和包含它们的试剂等。

    Biomarker specific for cancer
    6.
    发明授权
    Biomarker specific for cancer 失效
    针对癌症的生物标志物

    公开(公告)号:US08309687B2

    公开(公告)日:2012-11-13

    申请号:US12531358

    申请日:2008-03-13

    摘要: It is an object of the present invention to provide diagnostic reagents, pharmaceuticals and the like for particular diseases, and providing means that are useful in developing such reagents, pharmaceuticals and the like. The present invention provides a novel polypeptide and a specific partial peptide thereof, as well as a novel polynucleotide and a specific partial nucleotide thereof, that can be used as cancer-specific biomarkers; an expression vector for such a polynucleotide and a specific partial peptide thereof; a transformant incorporating such an expression vector; an antisense molecule, RNAi-inducing nucleic acid (e.g., siRNA), aptamer, or antibody for a cancer-specific biomarker, and a composition comprising the same; a mammalian cell or non-human mammal wherein the expression or a function of a cancer-specific biomarker is regulated; a measuring means (e.g., primer set, nucleic acid probe, antibody, aptamer) for a cancer-specific biomarker, and a reagent comprising them and the like.

    摘要翻译: 本发明的目的是为特定疾病提供诊断试剂,药物等,并提供可用于开发这些试剂,药物等的方法。 本发明提供了可用作癌症特异性生物标志物的新型多肽及其特异性部分肽,以及其新型多核苷酸及其特定部分核苷酸; 这种多核苷酸及其特定部分肽的表达载体; 包含这种表达载体的转化体; 用于癌特异性生物标志物的反义分子,RNAi诱导核酸(例如siRNA),适体或抗体,以及包含其的组合物; 哺乳动物细胞或非人哺乳动物,其中调节癌特异性生物标志物的表达或功能; 用于癌特异性生物标志物的测量装置(例如,引物组,核酸探针,抗体,适体)和包含它们的试剂等。

    BIOMARKER SPECIFIC TO BRAIN/NERVE OR SPECIFIC TO NEURONAL DIFFERENTIATION
    7.
    发明申请
    BIOMARKER SPECIFIC TO BRAIN/NERVE OR SPECIFIC TO NEURONAL DIFFERENTIATION 失效
    生物标志物特异性脑/神经或特异性神经元差异

    公开(公告)号:US20100098695A1

    公开(公告)日:2010-04-22

    申请号:US12531430

    申请日:2008-03-13

    摘要: The invention provides a polypeptide and a specific partial peptide thereof, as well as a polynucleotide and a specific partial nucleotide thereof, that can be used as a biomarker specific for the brain/nerves or specific for nerve differentiation; an expression vector for such a polynucleotide and a specific partial peptide thereof; a transformant incorporating such an expression vector; an antisense molecule, RNAi-inducing nucleic acid (e.g., siRNA), aptamer, or antibody for such a biomarker, and a composition comprising the same; a mammalian cell or non-human mammal wherein the expression or a function of such a biomarker is regulated; a measuring means (e.g., primer set, nucleic acid probe, antibody, aptamer) for such a biomarker, and a reagent comprising the same and the like.

    摘要翻译: 本发明提供了可用作脑/神经特异性或特异于神经分化的生物标志物的多肽及其特定部分肽以及其多核苷酸和特定的部分核苷酸; 这种多核苷酸及其特定部分肽的表达载体; 包含这种表达载体的转化体; 用于这种生物标志物的反义分子,RNAi诱导核酸(例如siRNA),适体或抗体,以及包含其的组合物; 哺乳动物细胞或非人哺乳动物,其中调节这种生物标志物的表达或功能; 用于这种生物标志物的测量装置(例如,引物组,核酸探针,抗体,适体)和包含该生物标记的试剂等。

    Solid-state image sensing device and method for manufacturing the same
    10.
    发明申请
    Solid-state image sensing device and method for manufacturing the same 有权
    固体摄像装置及其制造方法

    公开(公告)号:US20060022230A1

    公开(公告)日:2006-02-02

    申请号:US11155643

    申请日:2005-06-20

    IPC分类号: H01L21/00 H01L31/062

    摘要: In the solid-state image sensing device, a first N type semiconductor region and an N well of a PMOS region are formed in the same process, thereby making the first N type semiconductor region and the N well in the PMOS region substantially equal in N type impurity concentration-depth profile. By forming the first N type semiconductor region and the N well in the same process, the number of manufacturing process for the solid-state image sensing device can be decreased. It is, therefore, possible to suppress excessive application of heat history to the solid-state image sensing device during ion implantation and diffusion of N type impurity. Accordingly, by suppressing excessive diffusion of impurity and the like resulting from the excessive application of the heat history to the solid-state image sensing device, yield of the solid-state image sensing device can be improved.

    摘要翻译: 在固态摄像装置中,以相同的工序形成PMOS区域的第一N型半导体区域和N阱,由此使PMOS区域中的第一N型半导体区域和N阱在N上基本相等 型杂质浓度 - 深度剖面。 通过在相同的工艺中形成第一N型半导体区域和N阱,可以减少固态图像感测装置的制造工艺的数量。 因此,可以在N型杂质的离子注入和扩散期间抑制对固态摄像装置的过热应用。 因此,通过抑制由于过度地将热历史应用于固体摄像装置而导致的杂质等的过度扩散,能够提高固体摄像装置的产量。